These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1135 related items for PubMed ID: 27175707

  • 1. Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic Cancer.
    Im HJ, Oo S, Jung W, Jang JY, Kim SW, Cheon GJ, Kang KW, Chung JK, Kim EE, Lee DS.
    Medicine (Baltimore); 2016 May; 95(19):e3686. PubMed ID: 27175707
    [Abstract] [Full Text] [Related]

  • 2. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative ¹⁸F-FDG PET/CT in Patients with Pancreatic Cancer.
    Lee JW, Kang CM, Choi HJ, Lee WJ, Song SY, Lee JH, Lee JD.
    J Nucl Med; 2014 Jun; 55(6):898-904. PubMed ID: 24711649
    [Abstract] [Full Text] [Related]

  • 3. Prognostic significance of metabolic tumor volume and total lesion glycolysis in patients with advanced cervical carcinoma.
    Calles-Sastre L, Mucientes-Rasilla J, San-Frutos Llorente LM, Royuela A, Garcia-Espantaleón Navas M, Herrero Gámiz S, Pérez-Medina T.
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019 Jun; 38(1):17-21. PubMed ID: 30366731
    [Abstract] [Full Text] [Related]

  • 4. The correlation of 18F-FDG PET/CT metabolic parameters, clinicopathological factors, and prognosis in breast cancer.
    Qu YH, Long N, Ran C, Sun J.
    Clin Transl Oncol; 2021 Mar; 23(3):620-627. PubMed ID: 32683540
    [Abstract] [Full Text] [Related]

  • 5. Metabolic parameters of [18F]FDG PET-CT before and after radiotherapy may predict survival and recurrence in cervical cancer.
    Markus M, Sartor H, Bjurberg M, Trägårdh E.
    Acta Oncol; 2023 Feb; 62(2):180-188. PubMed ID: 36815676
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Usefulness of FDG PET/CT derived parameters in prediction of histopathological finding during the surgery in patients with pancreatic adenocarcinoma.
    Myssayev A, Myssayev A, Ideguchi R, Eguchi S, Adachi T, Sumida Y, Tobinaga S, Uetani M, Kudo T.
    PLoS One; 2019 Feb; 14(1):e0210178. PubMed ID: 30629646
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prediction of breast cancer recurrence using lymph node metabolic and volumetric parameters from 18F-FDG PET/CT in operable triple-negative breast cancer.
    Kim YI, Kim YJ, Paeng JC, Cheon GJ, Lee DS, Chung JK, Kang KW.
    Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1787-1795. PubMed ID: 28616695
    [Abstract] [Full Text] [Related]

  • 10. Prediction of Recurrence and Mortality of Locally Advanced Esophageal Cancer Patients Using Pretreatment F-18 FDG PET/CT Parameters: Intratumoral Heterogeneity, SUV, and Volumetric Parameters.
    Chang S, Kim SJ.
    Cancer Biother Radiopharm; 2016 Feb; 31(1):1-6. PubMed ID: 26844846
    [Abstract] [Full Text] [Related]

  • 11. Prognostic value of metabolic parameters on preoperative 18F-fluorodeoxyglucose positron emission tomography/ computed tomography in patients with stage III gastric cancer.
    Na SJ, o JH, Park JM, Lee HH, Lee SH, Song KY, Choi MG, Park CH.
    Oncotarget; 2016 Sep 27; 7(39):63968-63980. PubMed ID: 27564108
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H, Wroblewski K, Liao S, Kampalath R, Penney BC, Zhang Y, Pu Y.
    Acad Radiol; 2013 Jan 27; 20(1):32-40. PubMed ID: 22999369
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prognostic Value of the Sum of Metabolic Tumor Volume of Primary Tumor and Lymph Nodes Using 18F-FDG PET/CT in Patients With Cervical Cancer.
    Hong JH, Min KJ, Lee JK, So KA, Jung US, Kim S, Eo JS.
    Medicine (Baltimore); 2016 Mar 27; 95(9):e2992. PubMed ID: 26945420
    [Abstract] [Full Text] [Related]

  • 15. Prognostic value of 18 F-FDG PET/CT parameters in patients who undergo salvage treatments for recurrent squamous cell carcinoma of the larynx and hypopharynx.
    Lee JR, Almuhaimid TM, Roh JL, Oh JS, Kim SJ, Kim JS, Choi SH, Nam SY, Kim SY.
    J Surg Oncol; 2018 Sep 27; 118(4):644-650. PubMed ID: 30132891
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Metabolic tumour burden assessed by ¹⁸F-FDG PET/CT associated with serum CA19-9 predicts pancreatic cancer outcome after resection.
    Xu HX, Chen T, Wang WQ, Wu CT, Liu C, Long J, Xu J, Zhang YJ, Chen RH, Liu L, Yu XJ.
    Eur J Nucl Med Mol Imaging; 2014 Jun 27; 41(6):1093-102. PubMed ID: 24522797
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prognostic value of metabolic parameters determined by preoperative ¹⁸F-FDG PET/CT in patients with uterine carcinosarcoma.
    Lee HJ, Lee JJ, Park JY, Kim JH, Kim YM, Kim YT, Nam JH.
    J Gynecol Oncol; 2017 Jul 27; 28(4):e43. PubMed ID: 28541634
    [Abstract] [Full Text] [Related]

  • 20. Total lesion glycolysis by 18F-fluorodeoxyglucose positron emission tomography predicts tumor aggressiveness in patients with extrahepatic bile duct carcinoma.
    Fukushima R, Harimoto N, Kawai S, Ishii N, Tsukagoshi M, Igarashi T, Araki K, Tomonaga H, Higuchi T, Shirabe K.
    J Hepatobiliary Pancreat Sci; 2024 May 27; 31(5):339-350. PubMed ID: 38465467
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.